Covered recipient · General Payments record
JORDAN A GOODMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$504.85
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.95 | 11 |
| Education | $8.82 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $133.65 | 8 |
| Acerta Pharma LLC | $90.12 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $19.43 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104450632 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.34 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105793268 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.90 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105811583 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.45 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104763220 | CMS |
| Novo Nordisk Inc | $8.82 | 01/26/2024 | Education | Undisputed | 01/23/2026 | 1096878812 | CMS |
| Novo Nordisk Inc | $18.66 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096969061 | CMS |
| Novo Nordisk Inc | $21.13 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826254 | CMS |
| Novo Nordisk Inc | $16.76 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909129 | CMS |
| Novo Nordisk Inc | $24.77 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096855983 | CMS |
| Novo Nordisk Inc | $5.02 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097633356 | CMS |
| Novo Nordisk Inc | $19.06 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096634505 | CMS |
| Novo Nordisk Inc | $19.43 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096844094 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.